<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="correction" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1290431</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Barrio-Calvo</surname>
<given-names>Marina</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2113325"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kofoed</surname>
<given-names>S&#xf8;ren Vester</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2345868"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holste</surname>
<given-names>Sofie Cens</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2353327"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>S&#xf8;rensen</surname>
<given-names>Anders Bundg&#xe5;rd</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2209042"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Viborg</surname>
<given-names>Nadia</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2339119"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kringelum</surname>
<given-names>Jens Vindahl</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kleine-Kohlbrecher</surname>
<given-names>Daniela</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2415595"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steenmans</surname>
<given-names>Christian Skj&#xf8;dt</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thygesen</surname>
<given-names>Christian Bahne</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2388001"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>R&#xf8;n&#xf8;</surname>
<given-names>Birgitte</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2415588"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Friis</surname>
<given-names>Stine</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Evaxion Biotech</institution>, <addr-line>H&#xf8;rsholm</addr-line>, <country>Denmark</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Stine Friis, <email xlink:href="mailto:sf@evaxion-biotech.com">sf@evaxion-biotech.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1290431</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>09</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Barrio-Calvo, Kofoed, Holste, S&#xf8;rensen, Viborg, Kringelum, Kleine-Kohlbrecher, Steenmans, Thygesen, R&#xf8;n&#xf8; and Friis</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Barrio-Calvo, Kofoed, Holste, S&#xf8;rensen, Viborg, Kringelum, Kleine-Kohlbrecher, Steenmans, Thygesen, R&#xf8;n&#xf8; and Friis</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" xlink:href="10.3389/fimmu.2023.1234912" ext-link-type="doi">A Corrigendum on <article-title>Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine</article-title> by Barrio-Calvo M, Kofoed SV, Holste SC, S&#xf8;rensen AB, Viborg N, Kringelum JV, Kleine-Kohlbrecher D, Steenmans CS, Thygesen CB, R&#xf8;n&#xf8; B and Friis S (2023) <italic>Front. Immunol</italic>. 14:1234912. doi:&#xa0;<object-id>10.3389/fimmu.2023.1234912</object-id>
</related-article>
<kwd-group>
<kwd>APC-targeting</kwd>
<kwd>CCL19</kwd>
<kwd>neoantigens</kwd>
<kwd>DNA vaccine</kwd>
<kwd>cancer immunotherapy</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="1"/>
<word-count count="37"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Cancer Immunity and Immunotherapy</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there was an error in the Funding statement. The authors inadvertently omitted a funding disclosure that should have been included in the funding section of the manuscript. The correct Funding statement appears below.</p>
</body>
<back>
<sec id="s1" sec-type="funding-information">
<title>Funding</title>
<p>The Innovation Fund Denmark partially funded MB-C (1044-00028B) and NV (5189-00187B). The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</sec>
<sec id="s2" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>